Similarly, efforts to curb prescription painkiller abuse — for example, creating “abuse-deterrent” capsules — don’t seem to be as effective as hoped. “Making pills harder to crush and snort doesn’t make them less addictive,” says Kolodny…
Doctors were told that these patients didn’t face a high risk of addiction, “since the maker of Oxycontin saw a fear of addiction as a barrier to sales,” he says.
Actually, chronic pain patients don’t face a high risk of addiction. In fact, addiction rates for any drug are not high compared to the rest of the population — except in the case of cigarettes and alcohol, of course.
And Kolodny, didn’t you sell buprenorphine in the same ways? (See Wired article from 2005.)